Teza Capital Management’s Core Laboratories CLB Stock Holding History

Teza Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,441	Closed	-$159K	–	297
2020 Q3	$159K	Sell	10,441 -14,438	-58%	-$303K	0.09%	316
2020 Q2	$506K	Buy	+24,879	New	+$446K	0.11%	279
2020 Q1	–	Sell	-5,473	Closed	-$206K	–	190
2019 Q4	$206K	Buy	+5,473	New	+$246K	0.06%	505
2019 Q3	–	Sell	-6,288	Closed	-$329K	–	509
2019 Q2	$329K	Buy	+6,288	New	+$369K	0.19%	189
2019 Q1	–	Sell	-22,295	Closed	-$1.33M	–	313
2018 Q4	$1.33M	Buy	+22,295	New	+$1.92M	0.5%	56
2018 Q3	–	Sell	-13,346	Closed	-$1.68M	–	402
2018 Q2	$1.68M	Buy	+13,346	New	+$1.62M	0.25%	127

Other funds holding CLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Teza Capital Management's CLB Position: Q4 2020 in Review

Teza Capital Management sold out of Core Laboratories (CLB) in Q4 2020, closing a stake of 10,441 shares — an estimated $159K sold.

Teza Capital Management first reported a position in CLB in Q2 2018 and held it in 6 quarters. The position peaked at $1.68M in Q2 2018. 181 funds tracked by Wall St. Rank hold CLB as of Q4 2020.

Teza Capital Management reported no remaining Core Laboratories position as of Q4 2020 after selling out during the quarter.
Teza Capital Management sold 10,441 Core Laboratories shares in Q4 2020, an estimated $159K.
Teza Capital Management first reported a position in Core Laboratories in Q2 2018 and held it in 6 quarters.
Teza Capital Management's Core Laboratories position peaked at $1.68M in Q2 2018.
181 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2020.

Based on Teza Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.